NYSE:DVA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	13,691	825	N/A	2,275	4
12/31/2025	13,214	811	N/A	1,966	7
12/31/2024	12,682	775	N/A	1,946	7
3/31/2024	12,338	816	920	1,462	N/A
12/31/2023	12,140	692	1,491	2,059	N/A
9/30/2023	11,911	596	1,314	1,918	N/A
6/30/2023	11,739	454	1,357	1,967	N/A
3/31/2023	11,665	500	1,077	1,705	N/A
12/31/2022	11,610	547	961	1,565	N/A
9/30/2022	11,637	680	1,152	1,751	N/A
6/30/2022	11,627	834	995	1,607	N/A
3/31/2022	11,616	903	1,479	2,099	N/A
12/31/2021	11,619	978	1,289	1,931	N/A
9/30/2021	11,580	984	1,209	1,886	N/A
6/30/2021	11,566	883	1,124	1,802	N/A
3/31/2021	11,529	791	1,108	1,773	N/A
12/31/2020	11,551	783	1,304	1,979	N/A
9/30/2020	11,544	832	1,506	2,175	N/A
6/30/2020	11,524	824	1,648	2,333	N/A
3/31/2020	11,487	816	2,112	2,834	N/A
12/31/2019	11,388	705	1,730	2,496	N/A
9/30/2019	11,311	623	1,406	2,235	N/A
6/30/2019	11,253	548	1,124	2,011	N/A
3/31/2019	11,300	551	255	1,208	N/A
12/31/2018	11,412	616	544	1,531	N/A
9/30/2018	11,378	617	621	1,592	N/A
6/30/2018	11,299	698	698	1,679	N/A
3/31/2018	11,110	652	547	1,470	N/A
12/31/2017	10,884	909	N/A	1,966	N/A
9/30/2017	7,773	1,065	N/A	1,983	N/A
6/30/2017	8,732	1,480	N/A	2,016	N/A
3/31/2017	9,747	1,382	N/A	2,391	N/A
12/31/2016	10,696	1,038	N/A	1,988	N/A
9/30/2016	14,550	716	N/A	1,918	N/A
6/30/2016	14,347	361	N/A	2,061	N/A
3/31/2016	14,065	478	N/A	1,576	N/A
12/31/2015	9,973	323	N/A	1,531	N/A
9/30/2015	13,565	484	N/A	1,051	N/A
6/30/2015	13,290	452	N/A	1,219	N/A
3/31/2015	13,027	429	N/A	1,450	N/A
12/31/2014	12,781	723	N/A	1,459	N/A
9/30/2014	12,519	727	N/A	1,884	N/A
6/30/2014	12,270	680	N/A	1,769	N/A
3/31/2014	11,971	787	N/A	1,813	N/A
12/31/2013	11,759	620	N/A	1,773	N/A
9/30/2013	11,174	564	N/A	1,619	N/A
6/30/2013	10,121	572	N/A	1,253	N/A

アナリストによる今後の成長予測

収入対貯蓄率: DVAの予測収益成長率 (年間2.4% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: DVAの収益 ( 2.4% ) US市場 ( 14.8% ) よりも低い成長が予測されています。

高成長収益: DVAの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: DVAの収益 ( 4.1% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: DVAの収益 ( 4.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: DVAの自己資本利益率は、3年後には非常に高くなると予測されています ( 59.5 %)。

DaVita 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Price target increased by 9.0% to US$140

Price target increased by 7.4% to US$131

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Price target increased by 14% to US$120

Consensus EPS estimates increase by 13%

Price target increased by 7.3% to US$113

Recent updates

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Now 22% overvalued after recent price rise

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

Independent Director recently sold US$698k worth of stock

DaVita Appoints Madhu Narasimhan as Chief Information Officer, Effective June 3, 2024

Independent Director notifies of intention to sell stock

Price target increased by 9.0% to US$140

High number of new directors

DaVita Inc., Annual General Meeting, Jun 06, 2024

DaVita Inc. to Report Q1, 2024 Results on May 02, 2024

Davita Announces Dennis Pullin to Its Board of Directors

DaVita Stock Is A Hold As It Expands In Latin America

Chief Operating Officer of Kidney Care exercised options and sold US$3.0m worth of stock

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

CEO & Executive Director exercised options and sold US$36m worth of stock

Price target increased by 7.4% to US$131

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Chief Compliance Officer recently sold US$3.0m worth of stock

Chief Compliance Officer notifies of intention to sell stock

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Price target increased by 14% to US$120

Is DaVita (NYSE:DVA) Using Too Much Debt?

DaVita Inc. to Report Q4, 2023 Results on Feb 13, 2024

DaVita: Assessing After The Rally

DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

CEO & Executive Director exercised options and sold US$16m worth of stock

Investor sentiment improves as stock rises 15%

Consensus EPS estimates increase by 13%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

DaVita: Simple And Compelling After Sell-Off

Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

DaVita Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment deteriorates as stock falls 19%

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Chief Legal & Public Affairs Officer notifies of intention to sell stock

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Price target increased by 7.3% to US$113

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

DaVita Inc. Announces Management Changes

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

DaVita Inc. to Report Q2, 2023 Results on Aug 03, 2023

DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

Chief Legal & Public Affairs Officer recently sold US$1.0m worth of stock

CEO & Executive Director notifies of intention to sell stock

Price target increased by 8.1% to US$96.27

Price target increased by 8.3% to US$94.38

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

Price target increased by 8.6% to US$88.80

These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Director recently sold US$108k worth of stock

Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

Director exercised options and sold US$106k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Price target increased by 7.0% to US$86.50

DaVita HealthCare Partners Q4 2022 Earnings Preview

Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine

DaVita Inc. to Report Q4, 2022 Results on Feb 22, 2023

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Is DaVita (NYSE:DVA) A Risky Investment?

DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution

Consensus EPS estimates fall by 21%